Advance in Research of the Relationship between Obstructive Sleep Apnea Hypopnea Syndrome and Hypertension

Abstract

Abstract:

【Abstract】 Obstructive sleep apnea hypopnea syndrome (OSAHS) is closely associated with hypertension. It is one of the leading causes for some secondary hypertension. The comprehensive treatment is possibly good for the control of hypertension and cardiovascular and cerebrovascular disease in patients with OSAHS and hypertension.

Key words: Hypertension; Obstructive sleep apnea hypopnea syndrome; Ambulatory blood pressure

摘要：

【摘要】阻塞性睡眠呼吸暂停低通气综合征与高血压关系密切，可能是某些继发性高血压的主要病因之一，对合并阻塞性睡眠呼吸暂停低通气综合征的高血压患者采取综合性治疗对控制高血压及心脑血管病可能有益处。

关键词: 高血压; 阻塞性睡眠呼吸暂停低通气综合征; 动态血压

YU Feng-Chun, ZHOU Zheng-Hong. Advance in Research of the Relationship between Obstructive Sleep Apnea Hypopnea Syndrome and Hypertension[J]. Chinese Journal of Stroke, 2013, 8(09): 730-734.

于逢春，周正宏. 阻塞性睡眠呼吸暂停低通气综合征与高血压之间关系的研究进展[J]. 中国卒中杂志, 2013, 8(09): 730-734.

References

1 中华医学会呼吸病学分会睡眠呼吸障碍学组. 阻塞性睡眠呼吸暂停低通气综合征诊治指南(2011年修订版)[J]. 中华结核和呼吸杂志, 2012, 35:9-12.

2 Punjabi NM, Caffo BS, Goodwin JL, et al. Sleep-disordered breathing and mortality:a prospective cohort study[J]. PLoS Med, 2009, 6:e1000132.

3 Yaggi HK, Concato J, Kernan WN, et al. Obstructive sleep apnea as a risk factor for stroke and death[J]. N Engl J Med, 2005, 353:2034-2041.

4 Kohler M, Strading JR. Mechanisms of vascular damage in obstructive sleep apnea[J]. Nat Rev Cardiol, 2010, 7:677-685.

5 Punjabi NM. The epidemiology of adult obstructive sleep apnea[J]. Proc Am Thorac Soc, 2008, 5:136-143.

6 Somers VK, White DP, Amin R, et al. Sleep apnea and cardiovascular disease:an American Heart Association/American College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health)[J]. Circulation, 2008, 118:1080-1111.

7 Silverberg DS, Oksenberg A, Iaina A. Sleep-related breathing disorders as a major cause of essential hypertension:fact or fiction?[J]. Curr Opin Nephrol Hypertens, 1998, 7:353-357.

8 Nieto FJ, Young TB, Lind BK, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study[J]. JAMA, 2000, 283:1829-1836.

9 Young T, Peppard P, Palta M, et al. Population-based study of sleep-disordered breathing as a risk factor for hypertension[J]. Arch Intern Med, 1997, 157:1746-1752.

10 Peppard PE, Young T, Palta M, et al. Prospective study of the association between sleep-disordered breathing and hypertension[J]. N Engl J Med, 2000, 342:1378-1384.

11 李南方, 林丽, 王磊, 等. 1999-2008年高血压专科住院患者病因构成的分析[J]. 中华高血压杂志, 2011, 19:939-942.

12 Portaluppi F, Provini F, Cortelli P, et al. Undiagnosed sleep-disordered breathing among male nondippers with essential hypertension[J]. J Hypertens, 1997, 15:1227-1233.

13 Hla KM, Young T, Finn L, et al. Longitudinal association of sleep-disordered breathing and nondipping of nocturnal blood pressure in the Wisconsin Sleep Cohort Study[J]. Sleep, 2008, 31:795-800.

14 Lloberes P, Lozano L, Sampol G, et al. Obstructive sleep apnea and 24-h blood pressure in patients with resistant hypertension[J]. J Sleep Res, 2010, 19:597-602.

15 Chokroverty S. Sleep disorders medicine[M]. 3rd ed. Philadephia:Elsevier Inc. 2009:92-105.

16 Fletcher EC, Miller J, Schaaf JW, et al. Urinary catecholamines before and after tracheostomy in patients with obstructive sleep apnea and hypertension[J]. Sleep, 1987, 10:35-44.

17 Fletcher EC, Lesske J, Qian W, et al. Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in rats[J]. Hypertension, 1992, 19:555-561.

18 Lombardi C, Parati G, Cortelli P, et al. Daytime sleepiness and neural cardiac modulation in sleep-related breathing disorders[J]. J Sleep Res, 2008, 17:263-270.

19 Moller DS, Lind P, Strunge B, et al. Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea[J]. Am J Hypertens, 2003, 16:274-280.

20 Foster GE, Hanly PJ, Ahmed SB, et al. Intermittent hypoxia increases arterial blood pressure in humans through a renin-angiotensin system-dependent mechanism[J]. Hypertension, 2010, 56:369-377.

21 Koller A, Huang A. Impaired nitric oxide-mediated flow-induced dilation in arterioles of spontaneously hypertensive rats[J]. Circ Res, 1994, 74:416-421.

22 Suzuki YJ, Jain V, Park AM, et al. Oxidative stress and oxidant signaling in obstructive sleep apnea and associated cardiovascular diseases[J]. Free Radic Bio Med, 2006, 40:1683-1692.

23 Mohsenin V, Urbano F. Circulating antiangiogenic proteins in obstructive sleep apnea and hypertension[J]. Respir Med, 2011, 105:801-807.

24 Noda A, Nakata S, Koike Y, et al. Continuous positive airway pressure improves daytime baroreflex sensitivity and nitric oxide production in patients with moderate to severe obstructive sleep apnea syndrome[J]. Hypertens Res, 2007, 30:669-676.

25 Ip MS, Tse HF, Lam B, et al. Endothelial function in obstructive sleep apnea and response to treatment[J]. Am J Respir Crit Care Med, 2004, 169:348-353.

26 Cross MD, Mills NL, Al-Abri M, et al. Continuous positive airway pressure improves vascular function in obstructive sleep apnea/hypopnea syndrome:a randomised controlled trial[J]. Thorax, 2008, 63:578-583.

27 Lurbe E, Torro I, Aguilar F, et al. Added impact of obesity and insulin resistance in nocturnal blood pressure elevation in children and adolescents[J]. Hypertension, 2008, 51:635-641.

28 Punjabi NM, Shahar E, Redline S, et al. Sleep-disordered breathing, glucose intolerance, and insulin resistance:the Sleep Heart Health Study[J]. Am J Epidemiol, 2004, 160:521-530.

29 Lam JC, Mak JC, Ip MS, et al. Obesity, obstructive sleep apnea and metabolic syndrome[J]. Respirology, 2012, 17:223-236.

30 Riha RL, Diefenbach K, Jennum P, et al. Genetic aspects of hypertension and metabolic disease in the obstructive sleep apnea-hypopnea syndrome[J]. Sleep Med Rev, 2008, 2:49-63.

31 Marin JM, Agusti A, Villar I, et al. Association between treated and untreated obstructive sleep apnea and risk of hypertension[J]. JAMA, 2012, 307:2169-2176.

32 Parati G, Lombardi C, Hedner J, et al. Position paper on the management of patients with obstructive sleep apnea and hypertension:joint recommendations by the European Society of Hypertension, by the European Respiratory Society and by the members of European COST (COoperation in Scientific and Technological research) ACTION B26 on obstructive sleep apnea[J]. J Hypertens, 2012, 30:633-646.

33 Börgel J, Sanner BM, Keskin F, et al. Obstructive sleep apnea and blood pressure. Interaction between the blood pressure-lowering effects of positive airway pressure therapy and antihypertensive drugs[J]. Am J Hypertens, 2004, 17:1081-1087.

34 Ziegler MG, Milic M, Sun P. Antihypertensive therapy for patients with obstructive sleep apnea[J]. Curr Opin Nephrol Hypertens, 2011, 20:50-55.

35 Gaddam K, Pimenta E, Thomas SJ, et al. Spironolactone reduces severity of obstructive sleep apnea in patients with resistant hypertension:a preliminary report[J]. J Hum Hypertens, 2010, 24:532-537.

[1]	SONG Yanli, LIN Jie, WU Yiping, LI Xiaojing, LIU Gaifen, XIA Wenjing, ZHANG Yuying, ZHANG Xiaolin, LYU Chenran, ZHOU Hong, LI Kai, XUE Bin, CHEN Lingling, ZHANG Zhongbo, PENG Xiao. Epidemiological Survey on the Risk Factors of Cardio-Cerebrovascular Diseases among Residents in Handan and Influencing Factors of Awareness, Treatment and Control Rate of Hypertension [J]. Chinese Journal of Stroke, 2022, 17(12): 1360-1365.
[2]	YANG Hongchao, LIU Zhenqiang, MO Dapeng. Effect of Different Intracranial Venous Drainage Patterns on Stenting for Idiopathic Intracranial Hypertension with Venous Sinus Stenosis [J]. Chinese Journal of Stroke, 2022, 17(07): 737-741.
[3]	ZHU Cuiting, HU Wenli. Analysis on Risk Factors for Total Cerebral Small Vessel Disease Burden in Patients with Dizziness or Vertigo [J]. Chinese Journal of Stroke, 2022, 17(04): 354-359.
[4]	KONG Fang, HUANG Xu, WEI Lian, ZHAO Yi. Clinical Characteristics of Case Series of Takayasu Arteritis with Ischemic Stroke as the First Sympotom [J]. Chinese Journal of Stroke, 2021, 16(12): 1210-1216.
[5]	CHEN Zhengyu, CHEN Guofang, CHEN Tong, MA Dongjiao. Influencing Factors of Leukoaraiosis at Different Brain Regions in Patients with Intravenous Thrombolysis for Acute Ischemic Strok [J]. Chinese Journal of Stroke, 2021, 16(12): 1248-1252.
[6]	CAO Shuangshuang, ZHANG Xiaoyan, WANG Jianwei, ZHAO Lei, CHEN Hongbing, WANG Mingyu. The Related Factors of Early Neurological Deterioration after Intravenous Thrombolysis in Patients with Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2021, 16(12): 1253-1258.
[7]	JI Peng, QU Xue-Ping, JIANG Li-Min, GUO Xiang-Dong, SUN Gen, LIU Song-Can, MENG Fan-Chao, LI Xiao-Gang. Effect of Obstructive Sleep Apnea Hypopnea Syndrome on Cerebrovascular Reactivity in Patients with Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2021, 16(10): 1034-1038.
[8]	FAN Hua-Sheng,WEI Feng, ZHONG Shi-Mao, HU Bei-Quan, YANG Song, LIU Hai-Feng, WU Jing. Dynamic Changes of T Lymphocyte Subsets after Hypertensive Intracerebral Hemorrhage [J]. Chinese Journal of Stroke, 2021, 16(03): 283-287.
[9]	TIAN Yu, GUAN Ling, CHEN Jie, GONG Xi-Ping, DONG Ke-Hui, MO Da-Peng, WANG Yi-Long. Association between Red Blood Cell Distribution Width and Visual Impairment in Patients with Idiopathic Intracranial Hypertension [J]. Chinese Journal of Stroke, 2021, 16(01): 34-38.
[10]	SONG Yan-Li, LIN Jie,XIA Wen-Jing, XUE Bin, WU Yi-Ping. Association of Homocysteine with Mild Cognitive Impairment in Hypertension Patients [J]. Chinese Journal of Stroke, 2020, 15(12): 1322-1326.
[11]	CHEN Jie,LIU Jia, DONG Pei, DONG Ke-Hui, MO Da-Peng, WANG Yi-Long, ZHAO Xing-Quan, GONG Xi-Ping. Cerebral Blood Flow Autoregulation Assessment in Patients with Idiopathic Intracranial Hypertension [J]. Chinese Journal of Stroke, 2020, 15(11): 1218-1222.
[12]	ZHENG Hua-Guang, LIU Xiao-Nan, ZHANG Wei-Wei, ZHANG Long-You, WANG Rui-Qing, MENG Qing-Ying,DUAN Yun-Yun, LIU Ya-Ou, WANG Yong-Jun. Association of Hypertension and Hyperhomocysteinemia with Silent Brain Infarction in the Healthy [J]. Chinese Journal of Stroke, 2020, 15(08): 861-868.
[13]	YAO Ming, ZHOU Li-Xin, ZHU Yi-Cheng, PENG Bin, NI Jun. Topographic Characteristic and Clinical Significance of Cerebral Microbleeds in Patients with CADASIL [J]. Chinese Journal of Stroke, 2020, 15(04): 343-348.
[14]	HE Qian-Qian, FU Bing, ZHANG Zhao-Ting, LI Min, DONG Wan-Li. Characteristics of White Matter Lesions and Cerebral Hemodynamics in Patients with H Type Hypertension [J]. Chinese Journal of Stroke, 2020, 15(01): 22-27.
[15]	TANG Xin-Ying, KUANG Ze-Min, LU Xi-Feng. Progress of Central Nervous System (Pro) Renin Receptor in the Pathogenesis of Hypertension [J]. Chinese Journal of Stroke, 2019, 14(12): 1279-1282.